Graphite One could take a leading role in loosening China’s tight grip on the US graphite market by mining feedstock from its ...

The addition of pembrolizumab to chemoradiotherapy improved survival outcomes for women with high-risk, locally advanced ...

Garimpeiro columnist Barry FitzGerald explains why "record" copper prices aren't quite what they seem; plus, some discounted ...

Survivorship Care is highlighted, providing emotional, physical, and practical care for patients, along with other positive data to be aware of.

BNT327 combined with chemotherapy showed an overall response rate of 85.4% when used as a first-line treatment for ...

A first-line regimen involving pembrolizumab (Keytruda) and olaparib (Lynparza) significantly reduced the risk of disease ...

China's Shanshan enters reorganization, Japan's tariffs loom, and major milestones for Syrah Resources, Talga Group ...

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, ...

Innovent Biologics begins patient dosing in phase 3 study of IBI354 for platinum-resistant ovarian cancer: San Francisco Tuesday, March 25, 2025, 18:00 Hrs [IST] Innovent Biologic ...